Why the study?
Anxiety is prevalent in cardiovascular disease and impacts quality of life and outcomes, but its significance and clinical management have been neglected and research evidence remains limited.
Anxiety is prevalent in patients with cardiovascular diseases and impacts quality of life, requiring careful diagnosis and management similar to depression.
Answers are grounded in this paper and cite their sources.
Anxiety burden in CVD warrants clinical attention; leaves open optimal management strategies.
Anxiety is a commonly prevalent mental problem in patients with cardiovascular diseases (CVD), but its significance and clinical management have been neglected until recently. Similar to depression, anxiety has been demonstrated to be prevalent and hinging the quality of life and optimal outcome of patients with CVD. Although research evidence is still limited, clinical management for depression may be adopted for the care of anxiety in patients with CVD. Special attention needs to be paid when diagnosing anxiety disorder in patients with CVD because the fear may be a normal reaction of these patients and anxiety may manifest somatically.
No takes yet. Share an insight, caveat, or question.
Wei Jiang (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: